Invention Grant
- Patent Title: Antibodies against epidermal growth factor receptor (EGFR) and uses thereof
-
Application No.: US14847304Application Date: 2015-09-08
-
Publication No.: US09885087B2Publication Date: 2018-02-06
- Inventor: Raghida Bukhalid , Michael Feldhaus , Anne Richard , Neeraj Kohli , Eric Krauland , Jeffrey David Kearns , Alexey A. Lugovskoy , Ulrik Nielsen
- Applicant: Merrimack Pharmaceuticals, Inc.
- Applicant Address: US MA Cambridge
- Assignee: Merrimack Pharmaceuticals, Inc.
- Current Assignee: Merrimack Pharmaceuticals, Inc.
- Current Assignee Address: US MA Cambridge
- Agency: Nelson Mullins Riley & Scarborough LLP
- Agent Jane E. Remillard, Esq.; Jill Gorny Sloper, Esq.
- Main IPC: C07K16/28
- IPC: C07K16/28 ; A61K39/395 ; C12Q1/68 ; G01N33/574 ; G01N33/74 ; C07K16/32 ; A61K9/00 ; C07K16/30 ; C07K14/71 ; A61K39/00
Abstract:
Anti-EGFR antibodies, therapeutic compositions comprising combinations of anti-EGFR antibodies, as well as methods for using such antibodies and compositions to treat EGFR-related disorders (e.g., cancers), are disclosed.
Public/Granted literature
- US20150376284A1 ANTIBODIES AGAINST EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR) AND USES THEREOF Public/Granted day:2015-12-31
Information query
